CH460752A - Verfahren zur Herstellung neuer 9B,10a-Bisnorchol-22-aldehyde - Google Patents

Verfahren zur Herstellung neuer 9B,10a-Bisnorchol-22-aldehyde

Info

Publication number
CH460752A
CH460752A CH435966A CH435966A CH460752A CH 460752 A CH460752 A CH 460752A CH 435966 A CH435966 A CH 435966A CH 435966 A CH435966 A CH 435966A CH 460752 A CH460752 A CH 460752A
Authority
CH
Switzerland
Prior art keywords
bisnorchol
aldehydes
new
production
Prior art date
Application number
CH435966A
Other languages
English (en)
Inventor
Harmen Reerink Engbert
Westerhof Pieter
Louis Schoeler Hendri Frederik
Original Assignee
Philips Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Nv filed Critical Philips Nv
Publication of CH460752A publication Critical patent/CH460752A/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
CH435966A 1958-04-12 1959-04-09 Verfahren zur Herstellung neuer 9B,10a-Bisnorchol-22-aldehyde CH460752A (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
NL226774 1958-04-12
NL232312 1958-10-15
NL236884 1959-03-07
NL236834 1959-03-07

Publications (1)

Publication Number Publication Date
CH460752A true CH460752A (de) 1968-08-15

Family

ID=27483654

Family Applications (1)

Application Number Title Priority Date Filing Date
CH435966A CH460752A (de) 1958-04-12 1959-04-09 Verfahren zur Herstellung neuer 9B,10a-Bisnorchol-22-aldehyde

Country Status (1)

Country Link
CH (1) CH460752A (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115724897A (zh) * 2021-08-31 2023-03-03 四川澄华生物科技有限公司 一种胆甾酸及其衍生物的氧化除杂方法

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115724897A (zh) * 2021-08-31 2023-03-03 四川澄华生物科技有限公司 一种胆甾酸及其衍生物的氧化除杂方法
CN115724897B (zh) * 2021-08-31 2024-06-21 四川澄华生物科技有限公司 一种胆甾酸及其衍生物的氧化除杂方法

Similar Documents

Publication Publication Date Title
CH415632A (de) Verfahren zur Herstellung neuer 3-Pyrrolidylmethylamine
CH409892A (de) Verfahren zur Herstellung von Peroxo-monosulfaten
CH373059A (de) Verfahren zur Herstellung neuer Epoxydverbindungen
CH370780A (de) Verfahren zur Herstellung neuer Ferocene
CH426716A (de) Verfahren zur Herstellung einbügelbarer Einlagestoffe
CH379494A (de) Verfahren zur Herstellung neuer Halogenpregnene
CH387209A (de) Verfahren zur Herstellung von Schmiermitteln
CH370872A (de) Verfahren zur Herstellung spröder Hartfette
CH371795A (de) Verfahren zur Herstellung neuer 11,18-Oxido-steroide
CH364790A (de) Verfahren zur Herstellung neuer 1,3,4-Oxdiazole
CH407970A (de) Verfahren zur Herstellung neuer Telomerisate
CH390234A (de) Verfahren zur Herstellung von Vinylthioäthylthiolphosph3r- bzw, -phosphonsäureestern
CH396872A (de) Verfahren zur Herstellung neuer Harnstoffe
CH375351A (de) Verfahren zur Herstellung neuer 6,21-Difluor-9a-halogen-steroide
CH460752A (de) Verfahren zur Herstellung neuer 9B,10a-Bisnorchol-22-aldehyde
CH367824A (de) Verfahren zur Herstellung neuer Halogenandrostene
CH383372A (de) Verfahren zur Herstellung neuer 2-Fluorsteroide
CH397672A (de) Verfahren zur Herstellung von Tetraorganodiphosphinen
CH362072A (de) Verfahren zur Herstellung neuer Acylpiperidine
CH393356A (de) Verfahren zur Herstellung neuer Eisen-Komplexsalze
AT210889B (de) Verfahren zur Herstellung neuer, basisch substituierter 1-Amino-naphthole
AT217475B (de) Verfahren zur Herstellung neuer Äthylen-bis-dithiocarbamat-Manganverbindungen
CH366283A (de) Verfahren zur Herstellung neuer Dioxotetrahydropyridazine
AT234917B (de) Verfahren zur Herstellung neuer Halogenpregnene
CH367497A (de) Verfahren zur Herstellung neuer Cyclo-Steroide